Showing results (181-190 of 209) with videos related to

Sort By:
Pageof 21
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 11, 2015
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I MutationsChao-Hua Chiu, Cheng-Ta Yang, Jin-Yuan Shih, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2008
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapyReury-Perng Perng, Chih-Hsin Yang, Yuh-Min Chen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2022
Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for TaiwanLi-Hsin Chien, Tzu-Yu Chen, Chung-Hsing Chen, et al.
JAMA Network Open|November 13, 2023
Polygenic Risk Score, Environmental Tobacco Smoke, and Risk of Lung Adenocarcinoma in Never-Smoking Women in TaiwanBatel Blechter, Li-Hsin Chien, Tzu-Yu Chen, et al.
Oncotarget|December 13, 2017
EGFR mutation, smoking, and gender in advanced lung adenocarcinomaChien-Hua Tseng, Chun-Ju Chiang, Jeng-Sen Tseng, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 19, 2019
Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction ModelLi-Hsin Chien, Chung-Hsing Chen, Tzu-Yu Chen, et al.
American Journal of Respiratory and Critical Care Medicine|September 27, 2016
Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase InhibitorsI-Shou Chang, Shih Sheng Jiang, James Chih-Hsin Yang, et al.
Pageof 21